The abstract is read at the publisher; the summary is JClub's.
NKG2D overexpression in CAR-T cells (CAR-NG) reduces NK-cell–mediated cytotoxic susceptibility and improves tumor control in hematologic and solid tumor models.
- Why it matters: Durable CAR-T efficacy is limited by insufficient persistence, and activated CAR-T cells can become vulnerable to NK killing via upregulated NKG2D ligands.
- What they did: Activated CAR-T cells were found to upregulate multiple NKG2D ligands, and CAR-T cells were engineered to overexpress full-length NKG2D to test effects on ligand accessibility and tumor-driven costimulation.
- The result: In hematologic and solid tumor models, CAR-NG shows reduced NK-mediated cytotoxicity, improved tumor control, increased in vivo expansion and deeper infiltration, with no evident additional toxicity versus conventional CAR-T cells.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.